Jim Simons
TNYA icon

Jim Simons’s Tenaya Therapeutics TNYA Stock Holding History

Jim Simons’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.57M Buy
3,713,761
+1,862,894
+101% +$1.37M ﹤0.01% 1743
2025
Q4 		$1.32M Buy
1,850,867
+172,665
+10% +$235K ﹤0.01% 2121
2025
Q3 		$2.72M Sell
1,678,202
-165,677
-9% -$167K ﹤0.01% 1874
2025
Q2 		$1.13M Buy
1,843,879
+302,154
+20% +$154K ﹤0.01% 2452
2025
Q1 		$879K Buy
+1,541,725
New +$1.52M ﹤0.01% 2492
2024
Q4 		– Sell
-380,468
Closed -$734K – 3918
2024
Q3 		$734K Buy
380,468
+223,008
+142% +$630K ﹤0.01% 2609
2024
Q2 		$488K Buy
157,460
+92,960
+144% +$384K ﹤0.01% 2698
2024
Q1 		$337K Sell
64,500
-417,825
-87% -$2M ﹤0.01% 3041
2023
Q4 		$1.56M Buy
482,325
+48,725
+11% +$105K ﹤0.01% 2102
2023
Q3 		$1.11M Buy
433,600
+339,800
+362% +$1.42M ﹤0.01% 2229
2023
Q2 		$551K Sell
93,800
-171,100
-65% -$994K ﹤0.01% 2826
2023
Q1 		$755K Buy
264,900
+55,821
+27% +$157K ﹤0.01% 2654
2022
Q4 		$420K Buy
209,079
+42,879
+26% +$105K ﹤0.01% 3042
2022
Q3 		$482K Buy
+166,200
New +$776K ﹤0.01% 2944

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Jim Simons's TNYA Position: Q1 2026 in Review

Jim Simons increased its Tenaya Therapeutics (TNYA) stake by 101% in Q1 2026, buying an estimated $1.37M and bringing the position to 3,713,761 shares worth $2.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1743.

Jim Simons first reported a position in TNYA in Q3 2022 and has held it in 14 quarters since. The position peaked at $2.72M in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Jim Simons held 3,713,761 shares of Tenaya Therapeutics worth $2.57M as of Q1 2026.
  • Jim Simons bought 1,862,894 Tenaya Therapeutics shares in Q1 2026, an estimated $1.37M.
  • Tenaya Therapeutics made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #1743 holding.
  • Jim Simons first reported a position in Tenaya Therapeutics in Q3 2022 and has held it in 14 quarters since.
  • Jim Simons's Tenaya Therapeutics position peaked at $2.72M in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.